VeriMomresorcinol hamilelikte güvenli mi?
SCCS (EU Scientific Committee on Consumer Safety) identified endocrine‑disrupting/thyroid effects for resorcinol and set restricted safe use levels in cosmetics, indicating suspected reproductive/endocrine hazards though used at low concentrations (SCCS opinion). Animal toxicology (NTP/NIH gavage studies) shows systemic effects at higher doses including thyroid and other systemic toxicity, supporting a mechanistic concern. Topical cosmetic use can give low but measurable systemic exposure at typical consumer concentrations, so exposure is rated as low/measurable. ([health.ec.europa.eu](https://health.ec.europa.eu/publications/resorcinol_en?utm_source=openai))
Hamilelikte resorcinol yerine kullanılabilecek güvenli alternatifler | VeriMom
Related ingredients
Frequently asked questions
- resorcinol hamilelikte güvenli mi?
- SCCS (EU Scientific Committee on Consumer Safety) identified endocrine‑disrupting/thyroid effects for resorcinol and set restricted safe use levels in cosmetics, indicating suspected reproductive/endocrine hazards though used at low concentrations (SCCS opinion). Animal toxicology (NTP/NIH gavage studies) shows systemic effects at higher doses including thyroid and other systemic toxicity, supporting a mechanistic concern. Topical cosmetic use can give low but measurable systemic exposure at typical consumer concentrations, so exposure is rated as low/measurable. ([health.ec.europa.eu](https://health.ec.europa.eu/publications/resorcinol_en?utm_source=openai))
- resorcinol emzirirken güvenli mi?
- Same basis as pregnancy: mechanistic evidence for endocrine/thyroid activity (SCCS; toxicology studies) gives a suspected reproductive/endocrine hazard. For topical cosmetic use systemic exposure is expected to be low but measurable; therefore breastfeeding exposure risk is rated similarly. There are no strong human lactation transfer data specific to resorcinol in cosmetics. ([health.ec.europa.eu](https://health.ec.europa.eu/publications/resorcinol_en?utm_source=openai))
- resorcinol bebek cildi için güvenli mi?
- Hazard and mechanism scores follow the SCCS/toxicology evidence (suspected endocrine/thyroid effects). Exposure for infants (0–3 yr) is increased by +1 relative to adults because immature skin and higher surface‑area:weight raise potential per‑kg uptake from topical products; thus exposure is moderate. No infant‑specific dermal toxicity studies were identified. ([health.ec.europa.eu](https://health.ec.europa.eu/publications/resorcinol_en?utm_source=openai))
- VeriMom resorcinol nasıl puanlıyor?
- VeriMom resorcinol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 40/100 (orta risk) olarak puanlar.
- Hamilelikte resorcinol yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.